Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial biotechnology ...

A 21-year-old Clinton woman has been sentenced to 15 years in prison after pleading guilty to charges related to the February ...

Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Ensysce Biosciences, ...

Tonix Pharmaceuticals (TNXP) announced that TONMYATM is now commercially available at pharmacies by prescription in the United States. TONMYA is a ...

The presence of Butorphanol, an opioid analgesic classified as a Class 2 Prohibited Substance, was disclosed upon analysis of ...

TONMYA was approved by the FDA on August 15, 2025.

Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~~ Further Program Advancement Supported by ...

When you hear a statistic as startling as the rise in autism rates, your mind immediately searches for a reason. And like a ...

TONMYA (cyclobenzaprine HCl sublingual tablets) is a non-opioid analgesic taken once daily at bedtime for adults with fibromyalgia. The treatment was approved by the FDA on August 15, 2025, marking ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated ATLANTA, GEORGIA / ACCESS Newswire / November 11, 2025 / ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic ...